血浆葡萄糖水平高提高婴儿的心脏缺陷风险
|
By LabMedica International staff writers Posted on 26 Jan 2018 |

图片:在怀孕早期检验血液中的葡萄糖水平,评估先天性心脏病的风险(图片蒙Paras医院惠赐)。
多年来,医生们一直知道患糖尿病的妇女生小孩时婴儿心脏缺陷的风险更高,一些研究也显示,非糖尿病产妇的血糖水平与婴儿的心脏缺陷风险有关。
进行这类研究的一个难题是,非糖尿病孕妇的血糖水平不属常规测量项目。相反,孕妇一般在怀孕中期接受口腔葡萄糖耐受试验,以确定是否有妊娠期糖尿病,但进行这项试验时胎儿心脏早已成形。
美国加利福尼亚州斯坦福大学医学中心的一组科学家研究了19,107对母婴的病历,分娩日期是在2009到2015年之间。病历详细记载了产妇的产前护理,包括验血结果和孕期与产后给婴儿做的心脏诊断。科学家们分析了从估计的受孕日的四周前到妊娠第14周结束期间收集的任意血样的血液葡萄糖水平。拿到了2,292名受试者(13%)的早期葡萄糖测量值。他们还查看了妊娠20周左右时的口腔葡萄糖耐受试验(OGTT)结果,有不到一半的受试者——9,511人有这些数据。
排除怀孕前就有糖尿病或怀孕期间得糖尿病的妇女,结果显示,怀孕早期血液葡萄糖水平每升高10毫克/分升,生的小孩有先天性心脏缺陷的风险就升高8%。无先天性心脏缺陷(CHD)的怀孕早期血糖均值为96毫克/分升(5.3毫摩尔/升),而有CHD的怀孕早期血糖均值为107毫克/分升(6.0毫摩尔/升)。1小时OGTT均值分别为117毫克/分升(6.5 毫摩尔/升)和122毫克/分升(6.8毫摩尔/升)。
上述结果表明,怀孕早期测得的随机血浆葡萄糖值较高与无糖尿病产妇所生婴儿的先天性心脏病风险升高有关。再者,怀孕早期测得的血浆葡萄糖值与后代先天性心脏病风险的关联比OGTT更密切,OGTT常用于胎儿超声心动图筛查前的怀孕风险分级。
该研究的论文发表于2017年12月15日的《儿科杂志》(The Journal of Pediatrics)。资深作者、儿心内科助理教授James R. Priest大夫说:“小孩有先天性心脏病的妇女大多数没有糖尿病。我们发现,即使产妇没有糖尿病或在怀孕期间得糖尿病,我们仍能通过怀孕第一个三月期的葡萄糖值测到生的小孩有先天性心脏病的风险。”
Related Links:
斯坦福大学医学中心
进行这类研究的一个难题是,非糖尿病孕妇的血糖水平不属常规测量项目。相反,孕妇一般在怀孕中期接受口腔葡萄糖耐受试验,以确定是否有妊娠期糖尿病,但进行这项试验时胎儿心脏早已成形。
美国加利福尼亚州斯坦福大学医学中心的一组科学家研究了19,107对母婴的病历,分娩日期是在2009到2015年之间。病历详细记载了产妇的产前护理,包括验血结果和孕期与产后给婴儿做的心脏诊断。科学家们分析了从估计的受孕日的四周前到妊娠第14周结束期间收集的任意血样的血液葡萄糖水平。拿到了2,292名受试者(13%)的早期葡萄糖测量值。他们还查看了妊娠20周左右时的口腔葡萄糖耐受试验(OGTT)结果,有不到一半的受试者——9,511人有这些数据。
排除怀孕前就有糖尿病或怀孕期间得糖尿病的妇女,结果显示,怀孕早期血液葡萄糖水平每升高10毫克/分升,生的小孩有先天性心脏缺陷的风险就升高8%。无先天性心脏缺陷(CHD)的怀孕早期血糖均值为96毫克/分升(5.3毫摩尔/升),而有CHD的怀孕早期血糖均值为107毫克/分升(6.0毫摩尔/升)。1小时OGTT均值分别为117毫克/分升(6.5 毫摩尔/升)和122毫克/分升(6.8毫摩尔/升)。
上述结果表明,怀孕早期测得的随机血浆葡萄糖值较高与无糖尿病产妇所生婴儿的先天性心脏病风险升高有关。再者,怀孕早期测得的血浆葡萄糖值与后代先天性心脏病风险的关联比OGTT更密切,OGTT常用于胎儿超声心动图筛查前的怀孕风险分级。
该研究的论文发表于2017年12月15日的《儿科杂志》(The Journal of Pediatrics)。资深作者、儿心内科助理教授James R. Priest大夫说:“小孩有先天性心脏病的妇女大多数没有糖尿病。我们发现,即使产妇没有糖尿病或在怀孕期间得糖尿病,我们仍能通过怀孕第一个三月期的葡萄糖值测到生的小孩有先天性心脏病的风险。”
Related Links:
斯坦福大学医学中心
Latest 临床化学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







